Nothing Special   »   [go: up one dir, main page]

MX9206628A - Ester de prolinaboronato y metodo para su preparacion. - Google Patents

Ester de prolinaboronato y metodo para su preparacion.

Info

Publication number
MX9206628A
MX9206628A MX9206628A MX9206628A MX9206628A MX 9206628 A MX9206628 A MX 9206628A MX 9206628 A MX9206628 A MX 9206628A MX 9206628 A MX9206628 A MX 9206628A MX 9206628 A MX9206628 A MX 9206628A
Authority
MX
Mexico
Prior art keywords
prolinaboronate
ester
preparation
prolinaboronate ester
Prior art date
Application number
MX9206628A
Other languages
English (en)
Inventor
Roger Snow
Terence A Kelly
Julian Adams
Simon Coutts
Clark Perry
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MX9206628A publication Critical patent/MX9206628A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9206628A 1991-11-22 1992-11-18 Ester de prolinaboronato y metodo para su preparacion. MX9206628A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79614891A 1991-11-22 1991-11-22
US93619892A 1992-08-26 1992-08-26

Publications (1)

Publication Number Publication Date
MX9206628A true MX9206628A (es) 1993-05-01

Family

ID=27121696

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206628A MX9206628A (es) 1991-11-22 1992-11-18 Ester de prolinaboronato y metodo para su preparacion.

Country Status (17)

Country Link
EP (1) EP0641347A1 (es)
JP (1) JPH07501078A (es)
CN (1) CN1073946A (es)
AU (1) AU661362B2 (es)
CA (1) CA2123128A1 (es)
CZ (1) CZ124494A3 (es)
FI (1) FI942345A0 (es)
HU (1) HUT67937A (es)
IL (1) IL103817A0 (es)
MX (1) MX9206628A (es)
NO (1) NO941905L (es)
NZ (1) NZ245207A (es)
PT (1) PT101079A (es)
SI (1) SI9200332A (es)
SK (1) SK59294A3 (es)
TW (1) TW232697B (es)
WO (1) WO1993010127A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
TR200000815T2 (tr) 1997-09-29 2000-12-21 Point Therapeutics Inc. In vitro hematopoietik hücrelerin stimulasyonu.
BR9910251A (pt) 1998-05-04 2001-01-02 Point Therapeutics Inc Estimulação hematopoiética
BR9910907A (pt) 1998-06-05 2002-02-13 Point Therapeutics Inc Compostos cìclicos de boroprolina
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
EP1259246A2 (en) * 2000-02-25 2002-11-27 Novo Nordisk A/S Use of dpp-iv inhibitors for the treatment of diabetes
WO2003063903A2 (en) * 2002-02-01 2003-08-07 Probiodrug Ag Modulation of t lymphocytes using dp iv inhibitors
EA013684B1 (ru) * 2003-11-12 2010-06-30 Феномикс Корпорейшн Гетероциклические соединения бороновой кислоты
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
AU2004290897B2 (en) 2003-11-17 2009-02-26 Novartis Ag Use of dipeptidyl peptidase IV inhibitors
BR122018073405B1 (pt) 2004-01-20 2023-04-25 Novartis Ag Comprimido farmacêutico produzido por compressão direta compreendendo inibidor de dipeptidilpeptidase iv
AR049631A1 (es) * 2004-04-27 2006-08-23 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
JP2008545661A (ja) 2005-05-19 2008-12-18 ジェネンテック・インコーポレーテッド 線維芽細胞活性化タンパク質阻害剤化合物および
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN1331835C (zh) * 2005-10-18 2007-08-15 武汉大学 光活性β-羟基酮的制备方法
WO2007100374A2 (en) * 2005-12-19 2007-09-07 Trustees Of Tufts College Soft protease inhibitors and pro-soft forms thereof
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
SG10201404220TA (en) 2006-04-11 2014-10-30 Arena Pharm Inc Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
CN103497232A (zh) * 2008-06-17 2014-01-08 米伦纽姆医药公司 硼酸酯化合物及其医药组合物
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
WO2011127051A1 (en) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CA2812061A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US9523687B2 (en) 2014-02-28 2016-12-20 Institut Pasteur Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
SG11201609259VA (en) 2014-05-20 2016-12-29 Millennium Pharm Inc Boron-containing proteasome inhibitors for use after primary cancer therapy
MX2017011586A (es) 2015-03-09 2017-10-26 Intekrin Therapeutics Inc Metodos para el tratamiento de enfermedad de higado graso no alcoholico y/o lipodistrofia.
WO2018162722A1 (en) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Dpp-4 inhibitors for use in treating bone fractures
CN110996951A (zh) 2017-04-03 2020-04-10 科赫罗斯生物科学股份有限公司 治疗进行性核上性麻痹的PPARγ激动剂
CN108047257B (zh) * 2017-12-17 2020-03-13 沧州普瑞东方科技有限公司 一种手性n-boc-吡咯烷-2-硼酸的制备工艺
CN110452258B (zh) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 一种二肽缬氨酸硼脯氨酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
DK0528858T3 (da) * 1990-04-14 1997-07-28 Univ Tufts Med Inhibitorer af dipeptidyl-aminopeptidase type IV
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
PT101079A (pt) 1994-02-28
JPH07501078A (ja) 1995-02-02
IL103817A0 (en) 1993-04-04
EP0641347A1 (en) 1995-03-08
HUT67937A (en) 1995-05-29
AU661362B2 (en) 1995-07-20
CZ124494A3 (en) 1995-07-12
NO941905L (no) 1994-07-14
SK59294A3 (en) 1995-02-08
AU3136893A (en) 1993-06-15
TW232697B (es) 1994-10-21
CA2123128A1 (en) 1993-05-27
FI942345A (fi) 1994-05-20
HU9401350D0 (en) 1994-08-29
NZ245207A (en) 1994-07-26
FI942345A0 (fi) 1994-05-20
WO1993010127A1 (en) 1993-05-27
NO941905D0 (no) 1994-05-20
SI9200332A (en) 1993-06-30
CN1073946A (zh) 1993-07-07

Similar Documents

Publication Publication Date Title
MX9206628A (es) Ester de prolinaboronato y metodo para su preparacion.
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9202022A (es) Derivados de pirazina y proceso para su preparacion.
MX9102719A (es) Aparato y metodo para generar señales de cuadratura.
NO921218D0 (no) Reseptor-rensemetode
MX9204920A (es) Cianofenilpirroles y procedimiento para su obtencion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX9203836A (es) Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
MX9202536A (es) Antibioticos tetraciclicos y procedimiento para su preparacion.
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
MX9205457A (es) Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion
MX9204626A (es) Mensula de soporte y metodo para su fabricacion.
MX9202605A (es) Polimeros lineales y proceso para su preparacion.
MX9202327A (es) 2-aril pirroles substituidos y procedimiento para su obtencion.
MX9102324A (es) Pirimidilamidoximas substituidas y procedimiento para su obtencion.
MX9204843A (es) Pirazolinas substituidas y procedimiento para su obtencion.
MX9205346A (es) Diazacicloalcanos fosforilados y procedimiento para su obtencion.